siRNA, Anti-NRF1, 2'-OMe/2'-MOE/Ribo/Backbone-modified(CAT#: SIRGT16107WQ-2OMe)

The product SIRGT16107WQ-2OMe is a type of small interfering RNA (siRNA) that targets NRF1 gene and regulates the expression of gene. The siRNA interferes with the expression of NRF1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001040110.1; NM_001293163.1; NM_001293164.1; NM_005011.4
Alternative Names ALPHA-PAL
Related Diseases Skin Carcinoma In Situ, Oncocytoma
Purification HPLC
Target Gene
Gene ID 4899
Uniprot ID Q16656
Sub Cat Target Species Modification Scale  
SIRGT18107WQ-2MOE NRF1 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT16107WQ-RB NRF1 Human Ribo-modified Inquiry
SIRGT17107WQ-BB NRF1 Human Backbone-modified Inquiry

Related Products